Latest Revenue Growth News

Cleanaway Waste Management has refreshed its long-term strategy, Blueprint 2030 2.0, focusing on leveraging scale, digitisation, and targeted growth to boost margins and cash flow. The plan builds on solid FY25 financial gains and aims for sustained EPS growth and operational efficiency.

Nuix has completed its acquisition of Paris-based Linkurious, integrating advanced graph data visualisation technology and boosting its full year Annualised Contract Value guidance to $252 million–$272 million.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

ION Video has trimmed its monthly cash burn to $148,000, beating management’s forecast, and expects to maintain sufficient funding until at least mid-2027. Meanwhile, early-stage discussions with tech giants Meta and Alphabet remain active but non-binding.

Orthocell’s Q1 FY26 revenue hits $3.2 million, buoyed by growing US sales of its Remplir nerve repair device and a robust $48 million cash position supporting global expansion.

Worley Limited reveals the ongoing Middle East conflict is causing significant project delays and an estimated $30 to $40 million hit to FY26 underlying EBITA, prompting a revision to its growth outlook.

Monash IVF has turned down a revised $0.90 per share acquisition proposal from a consortium led by Genesis Capital and WHSP Holdings, citing significant undervaluation and confidence in its new CEO’s growth strategy.

SSH Group Ltd reported a 44% reduction in hire purchase debt alongside $48.4 million in rolling 12-month cash receipts, while progressing high-grade drilling and mining operations at Wagtail and Gold Duke projects.

Talius Group has reported its second consecutive quarter of positive operating cash flow, alongside an 11% annual increase in subscriptions and a $1.81 million revenue haul for Q1 FY26. The appointment of Pat Howard as CEO and a new $567k contract with Seventh-Day Adventist Aged Care signal momentum in the company’s push toward scalable growth.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Life360 has reported its first full year of profitability alongside a 32% revenue surge to $489.5 million in 2025, driven by user growth, new Pet GPS subscriptions, and a strategic advertising platform acquisition.